TELETRADER News
5/29, 12:07 PM (Source: TeleTrader)
more TeleTrader news

Sun Pharma approved to start COVID-19 treatment trial

Sun Pharmaceutical Industries Ltd. reported on Friday it received approval from Drugs Controller General of India to start a clinical trial for COVID-19 treatment with Nafamostat Mesilate.

Nafamostat, an anticoagulant used to treat acute pancreatitis, has been approved for human use in Japan and South Korea for over a decade.

Clinical trials of the drug have already started in Germany and Netherlands.

Breaking the News / MD